These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32652300)

  • 1. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
    Tehranian A; Ghahghaei-Nezamabadi A; Arab M; Khalagi K; Aghajani R; Sadeghi S
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101863. PubMed ID: 32652300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin for endometrial hyperplasia.
    Clement NS; Oliver TR; Shiwani H; Sanner JR; Mulvaney CA; Atiomo W
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012214. PubMed ID: 29077194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.
    Shan W; Wang C; Zhang Z; Gu C; Ning C; Luo X; Zhou Q; Chen X
    J Gynecol Oncol; 2014 Jul; 25(3):214-20. PubMed ID: 25045434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol.
    Zhao X; Niu J; Shi C; Liu Z
    Reprod Health; 2022 Nov; 19(1):206. PubMed ID: 36333773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The long-term efficacy of metformin in megestrol acetate-based fertility-sparing treatment for patients with endometrial atypical hyperplasia and endometrioid endometrial cancer].
    Dong YT; Guan J; Yang BY; Yierfulati G; Xue Y; Chen XJ
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):729-735. PubMed ID: 38462352
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiproliferative effect of metformin on the endometrium--a clinical trial.
    Tabrizi AD; Melli MS; Foroughi M; Ghojazadeh M; Bidadi S
    Asian Pac J Cancer Prev; 2014; 15(23):10067-70. PubMed ID: 25556427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Sharifzadeh F; Aminimoghaddam S; Kashanian M; Fazaeli M; Sheikhansari N
    Gynecol Endocrinol; 2017 Feb; 33(2):152-155. PubMed ID: 27690687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
    Kim MK; Seong SJ
    J Gynecol Oncol; 2014 Jul; 25(3):164-5. PubMed ID: 25045426
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparing the Administration of Letrozole and Megestrol Acetate in the Treatment of Women with Simple Endometrial Hyperplasia without Atypia: A Randomized Clinical Trial.
    Moradan S; Nikkhah N; Mirmohammadkhanai M
    Adv Ther; 2017 May; 34(5):1211-1220. PubMed ID: 28353144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women.
    Ravi RD; Kalra J; Srinivasan R; Bagga R; Jain V; Suri V; Sachdeva N
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):983-989. PubMed ID: 33773565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of drugs treatment in patients with endometrial hyperplasia with or without atypia: A systematic review and network meta-analysis.
    Yao Y; Xu S; Wang T; Jiang R
    Medicine (Baltimore); 2024 Sep; 103(38):e39619. PubMed ID: 39312359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
    Shen ZQ; Zhu HT; Lin JF
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
    Mitsuhashi A; Kawasaki Y; Hori M; Fujiwara T; Hanaoka H; Shozu M
    BMJ Open; 2020 Feb; 10(2):e035416. PubMed ID: 32114477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.
    Mitsuhashi A; Sato Y; Kiyokawa T; Koshizaka M; Hanaoka H; Shozu M
    Ann Oncol; 2016 Feb; 27(2):262-6. PubMed ID: 26578736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
    Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
    Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Masciullo V; Trivellizzi N; Zannoni G; Catena U; Moroni R; Fanfani F; Scambia G
    Am J Obstet Gynecol; 2021 Apr; 224(4):408-410. PubMed ID: 33385345
    [No Abstract]   [Full Text] [Related]  

  • 18. Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
    Shikeli S; Gowri V; Rawahi TA
    JBRA Assist Reprod; 2020 Oct; 24(4):466-469. PubMed ID: 32569453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
    Pautier P; Vergote I; Joly F; Melichar B; Kutarska E; Hall G; Lisyanskaya A; Reed N; Oaknin A; Ostapenko V; Zvirbule Z; Chetaille E; Geniaux A; Shoaib M; Green JA
    Int J Gynecol Cancer; 2017 Feb; 27(2):258-266. PubMed ID: 27870712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.